Christopher J. Calamari serves as Executive at ABBOTT LABORATORIES, where they oversee executive responsibilities. Since joining the company, Christopher J. Calamari has executed 7 insider transactions totaling $83.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 28, 2023 involved selling 2,827 shares valued at $282.0K.
Christopher J. Calamari currently holds 32,822 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Calamari has been a net seller of ABT stock. They have purchased $0 and sold $83.4K worth of shares.
Christopher J. Calamari's most recent insider trade was on Feb 28, 2023, when they sold 2,827 shares at $99.77 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 1, 2022 | ABT | $61.8K | Payment | 569 | $108.65 | Discretionary |
| Mar 1, 2022 | ABT | $83.4K | Sale | 706 | $118.15 | Discretionary |
| Feb 28, 2022 | ABT | $289.9K | Payment | 2,368 | $122.41 | Discretionary |
| Feb 18, 2022 | ABT | $0 | Award | 12,812 | $N/A | Discretionary |
| Jul 1, 2021 | ABT | $0 | Award | 3,764 | $N/A | Discretionary |